Eris Lifesciences Limited (BOM:540596)
1,361.35
-14.90 (-1.08%)
At close: Apr 27, 2026
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 183.93 billion as of April 28, 2026. Its market cap has increased by 2.23% in one year.
Market Cap
183.93B
Enterprise Value
211.19B
Revenue
30.65B
Ranking
n/a
PE Ratio
42.67
Stock Price
1,361.35
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 183.93B, an increase of 122.39%. That is a compound annual growth rate of 9.47%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Granules India | 170.76B |
| AstraZeneca Pharma India | 212.54B |
| Rubicon Research | 154.65B |
| Jubilant Pharmova | 149.60B |
| Caplin Point Laboratories | 130.50B |
| J. B. Chemicals & Pharmaceuticals | 321.75B |
| CORONA Remedies | 99.90B |
| Viyash Scientific | 90.17B |